Ovelle Bio Corp.
Biotechnology · DOVER, DE
BiotechnologySEC Form D
Ovelle Bio Corp. filed a Form D with the U.S. Securities and Exchange Commission on June 10, 2026, reporting $7,000,000 raised toward a $9,200,000 offering.
Incorporated in Delaware and based in DOVER, DE, it operates in the Biotechnology sector.
Companies file a Form D within 15 days of the first sale of securities in a private offering under Regulation D — an early, public signal that Ovelle Bio Corp. has raised capital from private investors.
Browse more recently funded companies in Biotechnology.
Executives & Directors
- Travis Carleton PotterExecutive Officer
- Merrick Pierson SmelaExecutive Officer
Recently funded in Biotechnology
Other companies that recently filed a Form D
$29.0KRaised
Thiogenesis Therapeutics, Corp.
$55.8MRaised
Contraline, Inc.
$22.9KRaised
Conexeu Sciences Inc.
$100.0KRaised
Barricade Therapeutics Corp
$1.2MRaised